149 related articles for article (PubMed ID: 10467409)
81. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
82. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.
Cai YC; Yang GY; Nie Y; Wang LD; Zhao X; Song YL; Seril DN; Liao J; Xing EP; Yang CS
Carcinogenesis; 2000 Apr; 21(4):683-9. PubMed ID: 10753204
[TBL] [Abstract][Full Text] [Related]
83. P73 status in B-cell chronic lymphocytic leukaemia.
Leupin N; Lüthi A; Novak U; Grob TJ; Hügli B; Graber H; Fey MF; Tobler A
Leuk Lymphoma; 2004 Jun; 45(6):1205-7. PubMed ID: 15360002
[TBL] [Abstract][Full Text] [Related]
84. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
Foulkes WD; Ragoussis J; Stamp GW; Allan GJ; Trowsdale J
Br J Cancer; 1993 Mar; 67(3):551-9. PubMed ID: 8094976
[TBL] [Abstract][Full Text] [Related]
85. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.
Yang A; Walker N; Bronson R; Kaghad M; Oosterwegel M; Bonnin J; Vagner C; Bonnet H; Dikkes P; Sharpe A; McKeon F; Caput D
Nature; 2000 Mar; 404(6773):99-103. PubMed ID: 10716451
[TBL] [Abstract][Full Text] [Related]
86. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
[TBL] [Abstract][Full Text] [Related]
87. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.
Arfaoui AT; Kriaa LB; El Hadj Oel A; Ben Hmida MA; Khiari M; Khalfallah T; Gharbi L; Mzabi S; Bouraoui S
Virchows Arch; 2010 Sep; 457(3):359-68. PubMed ID: 20644956
[TBL] [Abstract][Full Text] [Related]
88. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.
Allan GJ; Cottrell S; Trowsdale J; Foulkes WD
Hum Mutat; 1994; 3(3):283-91. PubMed ID: 8019564
[TBL] [Abstract][Full Text] [Related]
89. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
[TBL] [Abstract][Full Text] [Related]
90. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival.
Pfeifer D; Arbman G; Sun XF
Carcinogenesis; 2005 Jan; 26(1):103-7. PubMed ID: 15485994
[TBL] [Abstract][Full Text] [Related]
91. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
92. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
93. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
94. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
95. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
96. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
[TBL] [Abstract][Full Text] [Related]
97. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region.
Poetsch M; Dittberner T; Woenckhaus C
Melanoma Res; 2003 Feb; 13(1):29-33. PubMed ID: 12569282
[TBL] [Abstract][Full Text] [Related]
98. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
99. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
100. p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas.
Loiseau H; Arsaut J; Demotes-Mainard J
Neurosci Lett; 1999 Mar; 263(2-3):173-6. PubMed ID: 10213163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
